Kewaunee Scientific Q2 EPS $0.93 Up From $(0.09) YoY, Sales $50.44M Down From $54.56M YoY

12/6/23 4:48:31 PM ET

Medical Specialities

Industrials

Get the next $KEQU alert in real time by email

Kewaunee Scientific (NASDAQ:KEQU) reported quarterly earnings of $0.93 per share. This is a 1133.33 percent increase over losses of $(0.09) per share from the same period last year. The company reported $50.44 million in sales this quarter. This is a 7.57 percent decrease over sales of $54.56 million the same period last year.

Get the next $KEQU alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$KEQU

Date	Price Target	Rating	Analyst

More analyst ratings

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
STATESVILLE, N.C., Nov. 27, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its second quarter fiscal year 2025 financial results on Wednesday, December 11, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Nu Aire Founded in 1971 and based in Minneapolis, the Company is a leading manufacturer of equipment for a diverse range of laboratory and pharmacy environments. Nu Aire is the North American market share leader in biologi
11/27/24 4:05:00 PM ET
$KEQU
Medical Specialities
Industrials
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
STATESVILLE, N.C., Nov. 1, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) Kewaunee Scientific Corporation ("Kewaunee"), a leader in laboratory furniture and technical product design and manufacturing, today announced the successful acquisition of Nu Aire, a Minneapolis-based company, for $55 million, subject to certain adjustments for debt, cash, transaction expenses, and net working capital. Nu Aire is renowned for its manufacturing of biological safety cabinets, airflow products, CO2 incubators, ultralow freezers, animal handling equipment, pharmacy compo
11/1/24 8:01:00 AM ET
$KEQU
Medical Specialities
Industrials
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025
STATESVILLE, N.C., Sept. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its first quarter ended July 31, 2024. Fiscal Year 2025 First Quarter Results: Sales during the first quarter of fiscal year 2025 were $48,393,000, a decrease of 2.9% compared to sales of $49,839,000 from the prior year's first quarter. Pre-tax earnings for the quarter were $2,430,000 compared to $3,412,000 for the prior year quarter, a decrease of 28.8%. Net earnings were $2,193,000 compared to net earnings of $2,474,000 for the prior year quarter. EBITD
9/11/24 4:46:00 PM ET
$KEQU
Medical Specialities
Industrials

Kewaunee Scientific Q2 EPS $0.93 Up From $(0.09) YoY, Sales $50.44M Down From $54.56M YoY

Chat with this insight

Recent Analyst Ratings for
$KEQU

$KEQU
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Kewaunee Scientific Corporation

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

$KEQU
Press Releases

Fastest customizable press release news feed in the world

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025

Kewaunee Scientific Corporation Completes Acquisition of Nu Aire

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025

$KEQU
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Russell John bought $172,361 worth of shares (7,500 units at $22.98), increasing direct ownership by 30% to 32,500 units (SEC Form 4)

$KEQU
Market Insights

Live Market Insights

$KEQU
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$KEQU
SEC Filings

Kewaunee Scientific shares are trading higher following q4 earnings.

Kewaunee Scientific Q4 Adj EPS $1.55 Up From $0.34 YoY

Kewaunee Scientific shares are trading higher following q4 earnings.

President, CEO Hull Thomas David Iii exercised 12,000 shares at a strike of $20.13 and covered exercise/tax liability with 7,877 shares, increasing direct ownership by 10% to 46,497 units (SEC Form 4)

VP - Human Resources Phillips Elizabeth D exercised 9,000 shares at a strike of $19.58 and covered exercise/tax liability with 5,854 shares, increasing direct ownership by 26% to 15,441 units (SEC Form 4)

President, CEO Hull Thomas David Iii covered exercise/tax liability with 6,413 shares and converted options into 14,587 shares, increasing direct ownership by 24% to 42,374 units (SEC Form 4)

Kewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Kewaunee Scientific Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by Kewaunee Scientific Corporation

Kewaunee Scientific Q2 EPS $0.93 Up From $(0.09) YoY, Sales $50.44M Down From $54.56M YoY

Chat with this insight

Recent Analyst Ratings for $KEQU

$KEQU Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Kewaunee Scientific Corporation

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

$KEQU Press Releases

Fastest customizable press release news feed in the world

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025

Kewaunee Scientific Corporation Completes Acquisition of Nu Aire

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025

$KEQU Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Russell John bought $172,361 worth of shares (7,500 units at $22.98), increasing direct ownership by 30% to 32,500 units (SEC Form 4)

$KEQU Market Insights

Live Market Insights

$KEQU Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$KEQU SEC Filings

Kewaunee Scientific shares are trading higher following q4 earnings.

Kewaunee Scientific Q4 Adj EPS $1.55 Up From $0.34 YoY

Kewaunee Scientific shares are trading higher following q4 earnings.

President, CEO Hull Thomas David Iii exercised 12,000 shares at a strike of $20.13 and covered exercise/tax liability with 7,877 shares, increasing direct ownership by 10% to 46,497 units (SEC Form 4)

VP - Human Resources Phillips Elizabeth D exercised 9,000 shares at a strike of $19.58 and covered exercise/tax liability with 5,854 shares, increasing direct ownership by 26% to 15,441 units (SEC Form 4)

President, CEO Hull Thomas David Iii covered exercise/tax liability with 6,413 shares and converted options into 14,587 shares, increasing direct ownership by 24% to 42,374 units (SEC Form 4)

Kewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Kewaunee Scientific Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by Kewaunee Scientific Corporation

Recent Analyst Ratings for
$KEQU

$KEQU
Large Ownership Changes

$KEQU
Press Releases

$KEQU
Insider Purchases

$KEQU
Market Insights

$KEQU
Insider Trading

$KEQU
SEC Filings